|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Min TR, Park HJ, Park MN, Kim B and Park
SH: The root bark of morus alba L. suppressed the migration of
human non-small-cell lung cancer cells through inhibition of
epithelial-mesenchymal transition mediated by STAT3 and Src. Int J
Mol Sci. 20:2019. View Article : Google Scholar
|
|
4
|
Kalwa H and Michel T: The MARCKS protein
plays a critical role in phosphatidylinositol 4,5-bisphosphate
metabolism and directed cell movement in vascular endothelial
cells. J Biol Chem. 286:2320–2330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Green TD, Crews AL, Park J, Fang S and
Adler KB: Regulation of mucin secretion and inflammation in asthma:
A role for MARCKS protein? Biochim Biophys Acta. 1810:1110–1113.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arbuzova A, Schmitz AA and Vergères G:
Cross-talk unfolded: MARCKS proteins. Biochem J. 362:1–12. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sheats MK, Sung EJ, Adler KB and Jones SL:
In vitro neutrophil migration requires protein kinase C-delta
(δ-PKC)-mediated myristoylated alanine-rich C-kinase substrate
(MARCKS) phosphorylation. Inflammation. 38:1126–1141. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu D, Makkar G, Strickland DK, Blanpied
TA, Stumpo DJ, Blackshear PJ, Sarkar R and Monahan TS:
Myristoylated alanine-rich protein kinase substrate (MARCKS)
regulates small GTPase Rac1 and Cdc42 activity and is a critical
mediator of vascular smooth muscle cell migration in intimal
hyperplasia formation. J Am Heart Assoc. 4:e0022552015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iioka H, Ueno N and Kinoshita N: Essential
role of MARCKS in cortical actin dynamics during gastrulation
movements. J Cell Biol. 164:169–174. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang YW, Wei CY, Dai HP, Zhu ZY and Sun
YH: Subtractive phage display technology identifies zebrafish
marcksb that is required for gastrulation. Gene. 521:69–77. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dorris E, O'Neill A, Hanrahan K, Treacy A
and Watson RW: MARCKS promotes invasion and is associated with
biochemical recurrence in prostate cancer. Oncotarget.
8:72021–72030. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Su P, Zhi L and Zhao K: miR-34c-3p
acts as a tumor suppressor gene in osteosarcoma by targeting
MARCKS. Mol Med Rep. 15:1204–1210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Manai M, Thomassin-Piana J, Gamoudi A,
Finetti P, Lopez M, Eghozzi R, Ayadi S, Lamine OB, Manai M, Rahal
K, et al: MARCKS protein overexpression in inflammatory breast
cancer. Oncotarget. 8:6246–6257. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Z, Xu S, Jin P, Yang X, Li X, Wan D,
Zhang T, Long S, Wei X, Chen G, et al: MARCKS contributes to
stromal cancer-associated fibroblast activation and facilitates
ovarian cancer metastasis. Oncotarget. 7:37649–37663.
2016.PubMed/NCBI
|
|
15
|
Song J, Wang Q, Luo Y, Yuan P, Tang C, Hui
Y and Wang Z: miR-34c-3p inhibits cell proliferation, migration and
invasion of hepatocellular carcinoma by targeting MARCKS. Int J
Clin Exp Pathol. 8:12728–12737. 2015.PubMed/NCBI
|
|
16
|
El Amri M, Fitzgerald U and Schlosser G:
MARCKS and MARCKS-like proteins in development and regeneration. J
Biomed Sci. 25:432018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Björkblom B, Padzik A, Mohammad H,
Westerlund N, Komulainen E, Hollos P, Parviainen L, Papageorgiou
AC, Iljin K, Kallioniemi O, et al: c-Jun N-terminal kinase
phosphorylation of MARCKSL1 determines actin stability and
migration in neurons and in cancer cells. Mol Cell Biol.
32:3513–3526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fong LWR, Yang DC and Chen CH:
Myristoylated alanine-rich C kinase substrate (MARCKS): A multirole
signaling protein in cancers. Cancer Metastasis Rev. 36:737–747.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Chang S, Duncan SA, Okano HJ,
Fishell G and Aderem A: Disruption of the MacMARCKS gene prevents
cranial neural tube closure and results in anencephaly. Proc Natl
Acad Sci USA. 93:6275–6279. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Jarrett J, Huang CC, Satcher RL Jr
and Levenson AS: Identification of estrogen-responsive genes
involved in breast cancer metastases to the bone. Clin Exp
Metastasis. 24:411–422. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jonsdottir K, Zhang H, Jhagroe D, Skaland
I, Slewa A, Björkblom B, Coffey ET, Gudlaugsson E, Smaaland R,
Janssen EA and Baak JP: The prognostic value of MARCKS-like 1 in
lymph node-negative breast cancer. Breast Cancer Res Treat.
135:381–390. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Salem O, Erdem N, Jung J, Münstermann E,
Wörner A, Wilhelm H, Wiemann S and Körner C: The highly expressed
5′isomiR of hsa-miR-140-3p contributes to the tumor-suppressive
effects of miR-140 by reducing breast cancer proliferation and
migration. BMC Genomics. 17:5662016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karagoz K, Lehman HL, Stairs DB, Sinha R
and Arga KY: Proteomic and metabolic signatures of esophageal
squamous cell carcinoma. Curr Cancer Drug Targets. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei CY, Wang HP, Zhu ZY and Sun YH:
Transcriptional factors smad1 and smad9 act redundantly to mediate
zebrafish ventral specification downstream of smad5. J Biol Chem.
289:6604–6618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lánczky A, Nagy Á, Bottai G, Munkácsy G,
Szabó A, Santarpia L and Győrffy B: miRpower: A web-tool to
validate survival-associated miRNAs utilizing expression data from
2178 breast cancer patients. Breast Cancer Res Treat. 160:439–446.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ,
Liang SC, Lin CH, Whang-Peng J, Hsu SL, Chen CH and Huang CY:
Selection of DDX5 as a novel internal control for Q-RT-PCR from
microarray data using a block bootstrap re-sampling scheme. BMC
Genomics. 8:1402007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hou J, Aerts J, den Hamer B, van Ijcken W,
den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens
JA, Hoogsteden HC, et al: Gene expression-based classification of
non-small cell lung carcinomas and survival prediction. PLoS One.
5:e103122010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stearman RS, Dwyer-Nield L, Zerbe L,
Blaine SA, Chan Z, Bunn PA Jr, Johnson GL, Hirsch FR, Merrick DT,
Franklin WA, et al: Analysis of orthologous gene expression between
human pulmonary adenocarcinoma and a carcinogen-induced murine
model. Am J Pathol. 167:1763–1775. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Landi MT, Dracheva T, Rotunno M, Figueroa
JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et
al: Gene expression signature of cigarette smoking and its role in
lung adenocarcinoma development and survival. PLoS One.
3:e16512008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen CH, Thai P, Yoneda K, Adler KB, Yang
PC and Wu R: A peptide that inhibits function of Myristoylated
Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer
metastasis. Oncogene. 33:3696–3706. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen CH, Fong LWR, Yu E, Wu R, Trott JF
and Weiss RH: Upregulation of MARCKS in kidney cancer and its
potential as a therapeutic target. Oncogene. 36:3588–3598. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao J, Izumi T, Nunomura K, Satoh S and
Watanabe S: MARCKS-like protein, a membrane protein identified for
its expression in developing neural retina, plays a role in
regulating retinal cell proliferation. Biochem J. 408:51–59. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Naber HP, Drabsch Y, Snaar-Jagalska BE,
ten Dijke P and van Laar T: Snail and Slug, key regulators of
TGF-β-induced EMT, are sufficient for the induction of single-cell
invasion. Biochem Biophys Res Commun. 435:58–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ning J, Liu W, Zhang J, Lang Y and Xu S:
Ran GTPase induces EMT and enhances invasion in non-small cell lung
cancer cells through activation of PI3K-AKT pathway. Oncol Res.
21:67–72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wei R, Xiao Y, Song Y, Yuan H, Luo J and
Xu W: FAT4 regulates the EMT and autophagy in colorectal cancer
cells in part via the PI3K-AKT signaling axis. J Exp Clin Cancer
Res. 38:1122019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thul PJ, Åkesson L, Wiking M, Mahdessian
D, Geladaki A, Ait Blal H, Alm T, Asplund A, Björk L, Breckels LM,
et al: A subcellular map of the human proteome. Science. 356:2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
357:2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Seyfried TN and Huysentruyt LC: On the
origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cavallaro U: N-cadherin as an invasion
promoter: A novel target for antitumor therapy? Curr Opin Investig
Drugs. 5:1274–1278. 2004.PubMed/NCBI
|
|
49
|
Mendez MG, Kojima S and Goldman RD:
Vimentin induces changes in cell shape, motility, and adhesion
during the epithelial to mesenchymal transition. FASEB J.
24:1838–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Vuoriluoto K, Haugen H, Kiviluoto S,
Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB and Ivaska J:
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and
migration by governing Axl expression in breast cancer. Oncogene.
30:1436–1448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kidd ME, Shumaker DK and Ridge KM: The
role of vimentin intermediate filaments in the progression of lung
cancer. Am J Respir Cell Mol Biol. 50:1–6. 2014.PubMed/NCBI
|
|
52
|
Medici D, Hay ED and Olsen BR: Snail and
Slug promote epithelial-mesenchymal transition through
beta-catenin-T-cell factor-4-dependent expression of transforming
growth factor-beta3. Mol Biol Cell. 19:4875–4887. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xu W, Yang Z and Lu N: A new role for the
PI3K/Akt signaling pathway in the epithelial-mesenchymal
transition. Cell Adh Migr. 9:317–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Grille SJ, Bellacosa A, Upson J,
Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN and
Larue L: The protein kinase Akt induces epithelial mesenchymal
transition and promotes enhanced motility and invasiveness of
squamous cell carcinoma lines. Cancer Res. 63:2172–2178.
2003.PubMed/NCBI
|
|
56
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Carpenter RL, Paw I, Dewhirst MW and Lo
HW: Akt phosphorylates and activates HSF-1 independent of heat
shock, leading to Slug overexpression and epithelial-mesenchymal
transition (EMT) of HER2-overexpressing breast cancer cells.
Oncogene. 34:546–557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Altomare DA and Testa JR: Perturbations of
the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Dalva-Aydemir S, Bajpai R, Martinez M,
Adekola KU, Kandela I, Wei C, Singhal S, Koblinski JE, Raje NS,
Rosen ST and Shanmugam M: Targeting the metabolic plasticity of
multiple myeloma with FDA-approved ritonavir and metformin. Clin
Cancer Res. 21:1161–1171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Bajpai R, Matulis SM, Wei C, Nooka AK, Von
Hollen HE, Lonial S, Boise LH and Shanmugam M: Targeting glutamine
metabolism in multiple myeloma enhances BIM binding to BCL-2
eliciting synthetic lethality to venetoclax. Oncogene.
35:3955–3964. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mishra RK, Wei C, Hresko RC, Bajpai R,
Heitmeier M, Matulis SM, Nooka AK, Rosen ST, Hruz PW, Schiltz GE
and Shanmugam M: In silico modeling-based identification of glucose
transporter 4 (GLUT4)-selective inhibitors for cancer therapy. J
Biol Chem. 290:14441–14453. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wei C, Bajpai R, Sharma H, Heitmeier M,
Jain AD, Matulis SM, Nooka AK, Mishra RK, Hruz PW, Schiltz GE and
Shanmugam M: Development of GLUT4-selective antagonists for
multiple myeloma therapy. Eur J Med Chem. 139:573–586. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wei C, Heitmeier M, Hruz PW and Shanmugam
M: Evaluating the efficacy of GLUT inhibitors using a seahorse
extracellular flux analyzer. Methods Mol Biol. 1713:69–75. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Li Y, Martin LD, Spizz G and Adler KB:
MARCKS protein is a key molecule regulating mucin secretion by
human airway epithelial cells in vitro. J Biol Chem.
276:40982–40990. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Singer M, Martin LD, Vargaftig BB, Park J,
Gruber AD, Li Y and Adler KB: A MARCKS-related peptide blocks mucus
hypersecretion in a mouse model of asthma. Nat Med. 10:193–196.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ott LE, Sung EJ, Melvin AT, Sheats MK,
Haugh JM, Adler KB and Jones SL: Fibroblast migration is regulated
by myristoylated alanine-rich C-kinase substrate (MARCKS) protein.
PLoS One. 8:e665122013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Geng F, Zhu W, Anderson RA, Leber B and
Andrews DW: Multiple post-translational modifications regulate
E-cadherin transport during apoptosis. J Cell Sci. 125:2615–2625.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wahl JK III, Kim YJ, Cullen JM, Johnson KR
and Wheelock MJ: N-cadherin-catenin complexes form prior to
cleavage of the proregion and transport to the plasma membrane. J
Biol Chem. 278:17269–17276. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Detterbeck FC, Boffa DJ, Kim AW and Tanoue
LT: The eighth edition lung cancer stage classification. Chest.
151:193–203. 2017. View Article : Google Scholar : PubMed/NCBI
|
